Filing Details

Accession Number:
0001493152-20-013735
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-21 19:28:33
Reporting Period:
2020-07-13
Accepted Time:
2020-07-21 19:28:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382574 Trxade Group Inc. MEDS Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617460 Prashant Patel 3840 Land O'lakes Blvd
Land O'lakes FL 34639
President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-13 500 $5.71 1,274,500 No 4 S Direct
Common Stock Disposition 2020-07-14 7,000 $5.44 1,267,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 400,000 Indirect Through Patel Trust 2010 which Reporting Person controls as trustee
Common Stock 416,667 Indirect Through spouse
Footnotes
  1. The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person to satisfy the Reporting Person's tax liability in connection with the April 2020 grant of certain restricted stock which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3(b).
  2. Represents the weighted sales price for all sales made on July 14, 2020, which were made in a range of between ($5.31) and ($5.55) per share. The Reporting Person will provide to the Commission, the Issuer or any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.